Junk DNA May Kill Cancer Cells

Summary of the ScienceAlert ⁤Article: Targeting⁣ “Junk DNA”⁤ Activity in Blood Cancers

This ⁣ScienceAlert article details a new research approach to treating certain blood cancers (myelodysplastic syndrome ⁤and chronic lymphocytic leukemia) by targeting a surprising outcome of genetic ‍mutations. Here’s a breakdown of the key findings:

* The Problem: Mutations‍ in genes ASXL1 and EXH2 (common in these cancers) disrupt protein production and cause ⁢genomic instability. Conventional ⁣cancer therapies are ineffective because the mutated ⁢genes ⁢don’t produce⁤ proteins ⁣to target.
* The Discovery: Damage to ASXL1 and EXH2 leads to the reactivation⁢ of “junk DNA” – previously‍ thought to be non-functional – which then duplicates and spreads⁤ throughout the cancer ⁢cells’ genome.This creates stress within ⁢the cancer cells.
* The Vulnerability: To cope wiht this stress and continue growing, the cancer cells become dependent ‍ on ⁢PARP (poly (ADP-ribose) polymerase) repair proteins.
* The Solution: Researchers found that existing⁣ drugs that inhibit PARP (PARP inhibitors) were highly effective at killing the cancer cells, while largely sparing healthy cells. This creates a “synthetic lethality” – the cancer ⁤cells need PARP to survive the stress caused by ⁣the junk DNA activity, and ‍blocking PARP ⁣kills them.
* Potential Impact: This research offers a new therapeutic strategy for hard-to-treat cancers by repurposing existing drugs and targeting ⁤a previously overlooked aspect of cancer biology – the activity of “junk DNA.”

In essence,the research⁢ suggests that by exploiting ⁣the cancer cells’ reliance ‍on a DNA repair⁣ mechanism to deal ⁣with the ⁤chaos caused ⁤by reactivated junk DNA,scientists ⁣can selectively kill cancer cells. Further research is needed, but the findings are promising for developing new treatments.